<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01521260</url>
  </required_header>
  <id_info>
    <org_study_id>27147.042.09</org_study_id>
    <nct_id>NCT01521260</nct_id>
  </id_info>
  <brief_title>Implant Surface Decontamination in Peri-implantitis Treatment</brief_title>
  <official_title>Microbiological and Clinical Evaluation of Different Implant Surface Decontaminating Procedures in the Surgical Treatment of Peri-implantitis; a Double Blind Placebo Controlled Randomized Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Center Groningen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Center Groningen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Peri-implantitis is an infectious disease that resides in the mucosa surrounding dental
      implants and also affects the supporting bone. Because the number of implants placed in
      everyday clinical practice is continuously increasing, it is reasonable to anticipate an
      increasing prevalence of peri-implantitis. However, from the literature there is very little
      reliable evidence suggesting which could be the most effective interventions for treating
      peri-implantitis.

      The primary objective of this controlled clinical study is to evaluate the microbiological
      effect of decontamination of the implant surface during the surgical treatment of
      peri-implantitis using a chlorhexidine or placebo solution. The secondary objectives are to
      assess both the clinical and the microbiological effectiveness of treatment of
      peri-implantitis.

      It is hypothesized that rinsing of the implant surface using a 0.12% chlorhexidine solution
      does not lead to better microbiological and clinical results compared to rinsing with a
      placebo solution.

      The present study is a double-blind, placebo-controlled, randomized clinical trial.

      Adult patients with at least one endosseous implant in the oral cavity with clinical and
      radiographical signs of peri-implantitis will be included in this study.

      Implants with peri-implantitis lesions will be surgically exposed, followed by mechanical
      cleansing using curettes and gauzes and cotton pellets soaked in saline followed by either 1
      minute of rinsing with a placebo solution (saline with appearance of chlorhexidine) (control
      group) or 1 minute of chemical cleansing using 0,12% chlorhexidine + cetylpyridinium chloride
      (CPC) without alcohol (Perio-aid®) (test group). After 1 minute of saline rinsing the
      gingival flap will be returned slightly apical (in order to reduce pockets) and will be
      firmly sutured. For both groups the surgery is followed by 2 weeks of mouthrinses with 0,12%
      chlorhexidine + Cetylpyridinium Chloride (CPC) without alcohol (Perio-aid®) two times daily
      during 30 seconds.

      The main study parameter is the microbial composition of the biofilm on the dental implant
      surface. Secondary study parameters are bleeding on probing, probing pocket depth,
      suppuration on probing, microbiological composition of the peri-implant sulcus, radiographic
      marginal bone level on standardized intraoral radiographs, presence of plaque, presence of
      calculus, marginal soft tissue recession implant failure, complications and adverse events.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Total Bacterial Load on the Exposed Implant Surface</measure>
    <time_frame>During the surgical procedure: 1. immediately after flap deflection and granulation tissue removal AND 2. after the decontamination procedure but before flap closure.</time_frame>
    <description>Total bacterial load as obtained by sweeping a microbrush across the implant surface after flap deflection. Samples are obtained immediately after flap deflection and granulation tissue removal AND after the decontamination procedure (mechanical debridement, rinsing of the implant surface using the placebo or chlorhexidine solution, saline rinsing) but before flap closure. The log-transformed mean change in bacterial load is calculated (difference between the two time points --&gt; difference in sample BEFORE decontamination and AFTER decontamination procedure).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bleeding on Probing</measure>
    <time_frame>baseline (T0), 3, 6 and 12 months after intervention (T3, T6, T12)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Probing Pocket Depth</measure>
    <time_frame>baseline (T0), 3, 6 and 12 months after intervention (T3, T6, T12)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Suppuration on Probing</measure>
    <time_frame>baseline (T0), 3, 6 and 12 months after intervention (T3, T6, T12)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microbiological Composition of the Peri-implant Sulcus</measure>
    <time_frame>baseline (T0), 3 and 12 months after intervention (T3, T12)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic Marginal Bone Level on Standardized Intraoral Radiographs</measure>
    <time_frame>baseline (T0), 3, 6 and 12 months after intervention (T3, T6, T12)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of Plaque</measure>
    <time_frame>baseline (T0), 3, 6 and 12 months after intervention (T3, T6, T12)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of Calculus</measure>
    <time_frame>baseline (T0), 3, 6 and 12 months after intervention (T3, T6, T12)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Marginal Soft Tissue Recession</measure>
    <time_frame>baseline (T0), 3, 6 and 12 months after intervention (T3, T6, T12)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implant Failure</measure>
    <time_frame>baseline (T0), 3, 6 and 12 months after intervention (T3, T6, T12)</time_frame>
    <description>defined as implant mobility of previously clinically osseointegrated implants and removal of non-mobile implants because of progressive marginal bone loss or infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications and Adverse Events</measure>
    <time_frame>baseline (T0), 3, 6 and 12 months after intervention (T3, T6, T12)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Peri-implantitis</condition>
  <condition>Periodontal Disease</condition>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Implants with peri-implantitis lesions will be surgically exposed, followed by a mechanical cleansing using curettes and gauzes and cotton pellets soaked in saline, 1 minute of rinsing with a placebo solution (saline with appearance of chlorhexidine + CPC) and 1 minute of saline rinsing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chlorhexidine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Implants with peri-implantitis lesions will be surgically exposed, followed by a mechanical cleansing using curettes and gauzes and cotton pellets soaked in saline, 1 minute of chemical cleansing using 0,12% chlorhexidine + cetylpyridinium chloride (CPC) without alcohol (Perio-aid®) and 1 minute of saline rinsing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Implants with peri-implantitis lesions will be surgically exposed, followed by a mechanical cleansing using curettes and gauzes and cotton pellets soaked in saline, 1 minute of rinsing with a placebo solution (saline with appearance of chlorhexidine + CPC) and 1 minute of saline rinsing.</description>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Chlorhexidine</intervention_name>
    <description>Implants with peri-implantitis lesions will be surgically exposed, followed by a mechanical cleansing using curettes and gauzes and cotton pellets soaked in saline, 1 minute of chemical cleansing using 0,12% chlorhexidine + cetylpyridinium chloride (CPC) without alcohol (Perio-aid®) and 1 minute of saline rinsing.</description>
    <arm_group_label>Chlorhexidine group</arm_group_label>
    <other_name>Perio-aid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient is ≥ 18 years of age

          -  The patient has at least one endosseous implant in the oral cavity with clinical and
             radiographical signs of peri-implantitis. Peri-implantitis is defined as a loss of
             marginal bone ≥ 2 mm as compared to a fixed reference point on the dental implant, in
             combination with bleeding and/or suppuration on probing and a peri-implant probing
             depth ≥ 5 mm;

          -  The implants have been exposed to the oral environment for at least two years;

          -  The patient is capable of understanding and giving informed consent.

        Exclusion Criteria:

          -  Medical and general contraindications for the surgical procedures;

          -  A history of local radiotherapy to the head and neck region;

          -  Pregnancy and lactation;

          -  Diabetes;

          -  Systemic use of antibiotics during the last 3 months;

          -  Long-term use of anti-inflammatory drugs;

          -  Incapability of performing basal oral hygiene measures as a result of physical or
             mental disorders;

          -  Active, uncontrolled periodontal pathology of the remaining dentition;

          -  Local use of antibiotics or use of other anti-septic / antimicrobial therapies in the
             oral cavity during the last 3 months;

          -  Use of mouthrinses;

          -  Bruxism;

          -  Implants placed in skin grafted areas;

          -  Implants with bone loss due to other reasons than bacterial infection (e.g. loose
             screw, inadequate positioning of the implant);

          -  Implants with bone loss exceeding 2/3 of the length of the implant or implants with
             bone loss beyond the transverse openings in hollow implants;

          -  Implant mobility;

          -  Implants at which no position can be identified where proper probing measurements can
             be performed;

          -  Previous surgical treatment of the peri-implantitis lesions;

          -  Previous non-surgical treatment of the peri-implantitis lesions during the last 6
             months (scaling or curretage).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yvonne CM de Waal, dds</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center Groningen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arie Jan van Winkelhoff, prof. dr.</last_name>
    <role>Study Chair</role>
    <affiliation>University Medical Center Groningen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9700RB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 18, 2012</study_first_submitted>
  <study_first_submitted_qc>January 25, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2012</study_first_posted>
  <results_first_submitted>May 3, 2013</results_first_submitted>
  <results_first_submitted_qc>June 28, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 2, 2013</results_first_posted>
  <last_update_submitted>June 28, 2013</last_update_submitted>
  <last_update_submitted_qc>June 28, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 2, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Center Groningen</investigator_affiliation>
    <investigator_full_name>Yvonne CM de Waal</investigator_full_name>
    <investigator_title>drs.</investigator_title>
  </responsible_party>
  <keyword>dental implants</keyword>
  <keyword>microbiology</keyword>
  <keyword>chlorhexidine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontal Diseases</mesh_term>
    <mesh_term>Gingival Diseases</mesh_term>
    <mesh_term>Peri-Implantitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
    <mesh_term>Cetylpyridinium</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>recruitment period: october 2009-september 2010 location: University Medical Center Groningen</recruitment_details>
      <pre_assignment_details>Assessed for eligibility:55 patients Excluded 25, because 'not meeting inclusion criteria (n=20) or 'declined to participate' (n=5)</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Placebo Group</title>
          <description>Implants with peri-implantitis lesions will be surgically exposed, followed by a mechanical cleansing using curettes and gauzes and cotton pellets soaked in saline, 1 minute of rinsing with a placebo solution (saline with appearance of chlorhexidine + CPC) and 1 minute of saline rinsing.</description>
        </group>
        <group group_id="P2">
          <title>Chlorhexidine Group</title>
          <description>Implants with peri-implantitis lesions will be surgically exposed, followed by a mechanical cleansing using curettes and gauzes and cotton pellets soaked in saline, 1 minute of chemical cleansing using 0,12% chlorhexidine + cetylpyridinium chloride (CPC) without alcohol (Perio-aid®) and 1 minute of saline rinsing.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebo Group</title>
          <description>Implants with peri-implantitis lesions will be surgically exposed, followed by a mechanical cleansing using curettes and gauzes and cotton pellets soaked in saline, 1 minute of rinsing with a placebo solution (saline with appearance of chlorhexidine + CPC) and 1 minute of saline rinsing.</description>
        </group>
        <group group_id="B2">
          <title>Chlorhexidine Group</title>
          <description>Implants with peri-implantitis lesions will be surgically exposed, followed by a mechanical cleansing using curettes and gauzes and cotton pellets soaked in saline, 1 minute of chemical cleansing using 0,12% chlorhexidine + cetylpyridinium chloride (CPC) without alcohol (Perio-aid®) and 1 minute of saline rinsing.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="30"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61.5" spread="10.0"/>
                    <measurement group_id="B2" value="59.4" spread="14.0"/>
                    <measurement group_id="B3" value="60.4" spread="12.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Netherlands</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Total Bacterial Load on the Exposed Implant Surface</title>
        <description>Total bacterial load as obtained by sweeping a microbrush across the implant surface after flap deflection. Samples are obtained immediately after flap deflection and granulation tissue removal AND after the decontamination procedure (mechanical debridement, rinsing of the implant surface using the placebo or chlorhexidine solution, saline rinsing) but before flap closure. The log-transformed mean change in bacterial load is calculated (difference between the two time points --&gt; difference in sample BEFORE decontamination and AFTER decontamination procedure).</description>
        <time_frame>During the surgical procedure: 1. immediately after flap deflection and granulation tissue removal AND 2. after the decontamination procedure but before flap closure.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo Group</title>
            <description>Implants with peri-implantitis lesions will be surgically exposed, followed by a mechanical cleansing using curettes and gauzes and cotton pellets soaked in saline, 1 minute of rinsing with a placebo solution (saline with appearance of chlorhexidine + CPC) and 1 minute of saline rinsing.</description>
          </group>
          <group group_id="O2">
            <title>Chlorhexidine Group</title>
            <description>Implants with peri-implantitis lesions will be surgically exposed, followed by a mechanical cleansing using curettes and gauzes and cotton pellets soaked in saline, 1 minute of chemical cleansing using 0,12% chlorhexidine + cetylpyridinium chloride (CPC) without alcohol (Perio-aid®) and 1 minute of saline rinsing.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Total Bacterial Load on the Exposed Implant Surface</title>
          <description>Total bacterial load as obtained by sweeping a microbrush across the implant surface after flap deflection. Samples are obtained immediately after flap deflection and granulation tissue removal AND after the decontamination procedure (mechanical debridement, rinsing of the implant surface using the placebo or chlorhexidine solution, saline rinsing) but before flap closure. The log-transformed mean change in bacterial load is calculated (difference between the two time points --&gt; difference in sample BEFORE decontamination and AFTER decontamination procedure).</description>
          <units>log (colony forming units/ml)</units>
          <param>Log Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.77" spread="2.12"/>
                    <measurement group_id="O2" value="4.21" spread="1.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Bleeding on Probing</title>
        <time_frame>baseline (T0), 3, 6 and 12 months after intervention (T3, T6, T12)</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Probing Pocket Depth</title>
        <time_frame>baseline (T0), 3, 6 and 12 months after intervention (T3, T6, T12)</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Suppuration on Probing</title>
        <time_frame>baseline (T0), 3, 6 and 12 months after intervention (T3, T6, T12)</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Microbiological Composition of the Peri-implant Sulcus</title>
        <time_frame>baseline (T0), 3 and 12 months after intervention (T3, T12)</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Radiographic Marginal Bone Level on Standardized Intraoral Radiographs</title>
        <time_frame>baseline (T0), 3, 6 and 12 months after intervention (T3, T6, T12)</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Presence of Plaque</title>
        <time_frame>baseline (T0), 3, 6 and 12 months after intervention (T3, T6, T12)</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Presence of Calculus</title>
        <time_frame>baseline (T0), 3, 6 and 12 months after intervention (T3, T6, T12)</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Marginal Soft Tissue Recession</title>
        <time_frame>baseline (T0), 3, 6 and 12 months after intervention (T3, T6, T12)</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Implant Failure</title>
        <description>defined as implant mobility of previously clinically osseointegrated implants and removal of non-mobile implants because of progressive marginal bone loss or infection</description>
        <time_frame>baseline (T0), 3, 6 and 12 months after intervention (T3, T6, T12)</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Complications and Adverse Events</title>
        <time_frame>baseline (T0), 3, 6 and 12 months after intervention (T3, T6, T12)</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Placebo Group</title>
          <description>Implants with peri-implantitis lesions will be surgically exposed, followed by a mechanical cleansing using curettes and gauzes and cotton pellets soaked in saline, 1 minute of rinsing with a placebo solution (saline with appearance of chlorhexidine + CPC) and 1 minute of saline rinsing.</description>
        </group>
        <group group_id="E2">
          <title>Chlorhexidine Group</title>
          <description>Implants with peri-implantitis lesions will be surgically exposed, followed by a mechanical cleansing using curettes and gauzes and cotton pellets soaked in saline, 1 minute of chemical cleansing using 0,12% chlorhexidine + cetylpyridinium chloride (CPC) without alcohol (Perio-aid®) and 1 minute of saline rinsing.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Y.C.M. de Waal</name_or_title>
      <organization>University Medical Center Groningen - Center for dentistry and oral hygiene</organization>
      <phone>+31 50-3639051</phone>
      <email>y.c.m.de.waal@umcg.nl</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

